Devayani Kolhe

发表

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines

J. Tejedor, J. Brzostek, R. Konior, 2016, Clinical and Vaccine Immunology.

Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study.

H. Marshall, S. Halperin, K. Perrett, 2018, Vaccine.

Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age.

S. Kuriyakose, O. Van Der Meeren, Devayani Kolhe, 2012, Vaccine.

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents

A. Dubey, B. Quiambao, A. Bavdekar, 2017, Human vaccines & immunotherapeutics.

Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.

P. Kosina, N. Shah, N. Klein, 2018, Vaccine.

Haemophilus influenzae type b-Neisseria meningitidis Serogroup C or MenC Conjugate 2

J. Tejedor, J. Brzostek, R. Konior, 2016 .

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers

H. Marshall, R. Booy, M. Nissen, 2015, The Pediatric infectious disease journal.

Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies

I. Dieussaert, J. Wysocki, J. Brzostek, 2016, Human vaccines & immunotherapeutics.

10865-year Antibody Persistence and Booster Response to a Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults

R. Baxter, Devayani Kolhe, Y. Baine, 2014 .

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized Trial

T. Fischbach, A. Carmona Martínez, J. M. Merino Arribas, 2018, The Pediatric infectious disease journal.

Etiology of acute otitis media and serotype distribution of Streptococcus pneumoniae and Haemophilus influenzae in Chilean children <5 years of age

Devayani Kolhe, E. Ortega-Barria, A. Rosenblut, 2017, Medicine.

Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents

A. Dubey, B. Quiambao, A. Bavdekar, 2016, Human vaccines & immunotherapeutics.

Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial

R. Baxter, Devayani Kolhe, Y. Baine, 2015, The Pediatric infectious disease journal.

Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized Trial

T. Fischbach, A. Carmona Martínez, J. M. Merino Arribas, 2017, The Pediatric infectious disease journal.

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

Devayani Kolhe, R. Colindres, A. Linhares, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children

N. Klein, Devayani Kolhe, Y. Baine, 2016, The Pediatric infectious disease journal.

Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccine.

M. Knuf, Devayani Kolhe, Y. Baine, 2018, Vaccine.

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial

Z. Memish, Devayani Kolhe, M. van der Wielen, 2015, BMC Infectious Diseases.

An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.

S. Kuriyakose, N. Klein, L. Friedland, 2012, Vaccine.